Pathstone Holdings
PFE icon

Pathstone Holdings’s Pfizer PFE Stock Holding History

Pathstone Holdings’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.8M Buy
652,887
+17,861
+3% +$467K 0.05% 250
2026
Q1 		$17.8M Buy
635,026
+65,951
+12% +$1.76M 0.07% 202
2025
Q4 		$14.2M Buy
569,075
+21,619
+4% +$545K 0.05% 238
2025
Q3 		$13.9M Buy
547,456
+31,942
+6% +$788K 0.05% 243
2025
Q2 		$12.5M Sell
515,514
-335,425
-39% -$7.82M 0.05% 260
2025
Q1 		$21.5M Buy
850,939
+290,003
+52% +$7.59M 0.09% 160
2024
Q4 		$14.9M Sell
560,936
-85,935
-13% -$2.33M 0.07% 205
2024
Q3 		$18.7M Buy
646,871
+44,975
+7% +$1.31M 0.08% 176
2024
Q2 		$16.8M Sell
601,896
-31,550
-5% -$869K 0.08% 183
2024
Q1 		$17.6M Buy
633,446
+124,342
+24% +$3.45M 0.08% 173
2023
Q4 		$14.8M Buy
+509,104
New +$15.4M 0.08% 187

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Pathstone Holdings's PFE Position: Q2 2026 in Review

Pathstone Holdings increased its Pfizer (PFE) stake by 2.8% in Q2 2026, buying an estimated $467K and bringing the position to 652,887 shares worth $15.8M. The position accounts for 0.05% of the portfolio, ranked #250.

Pathstone Holdings first reported a position in PFE in Q4 2023 and has held it in 11 quarters since. The position peaked at $21.5M in Q1 2025. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Pathstone Holdings held 652,887 shares of Pfizer worth $15.8M as of Q2 2026.
  • Pathstone Holdings bought 17,861 Pfizer shares in Q2 2026, an estimated $467K.
  • Pfizer made up 0.05% of Pathstone Holdings's portfolio in Q2 2026, its #250 holding.
  • Pathstone Holdings first reported a position in Pfizer in Q4 2023 and has held it in 11 quarters since.
  • Pathstone Holdings's Pfizer position peaked at $21.5M in Q1 2025.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.